Pilot Study PBSCT with TCRab Depletion for Hemoglobinopathies

NAActive, not recruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 14, 2020

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2027

Conditions
Sickle Cell DiseaseThalassemia Major
Interventions
DEVICE

CliniMACS

Peripheral blood stem cells from closely matched unrelated donors will be processed using the CliniMACS device to remove TCRalpha/beta T cells and B cells, in accordance with the Investigator Brochure and Technical Manual following the laboratory standard operating procedures (SOPs) and using aseptic technique

Trial Locations (1)

19104

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
lead

Timothy Olson

OTHER